Madelon Paauwe

1.2k citations

16 papers · 805 indexed · h-index 13

Co-authors: Lukas J.A.C. Hawinkels Peter ten Dijke Cornelis F.M. Sier Eliza Wiercinska Wilma E. Mesker Kattria van der Ploeg Pim J. Koelink Hein W. Verspaget
Topics: Cancer, Hypoxia, and Metabolism (8 papers)TGF-β signaling in diseases (7 papers)Angiogenesis and VEGF in Cancer (3 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Blood Cancer Research Oncogene
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Madelon Paauwe

15 papers receiving 799 citations

Peers

Countries citing papers authored by Madelon Paauwe

Since Specialization

Citations

This map shows the geographic impact of Madelon Paauwe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madelon Paauwe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madelon Paauwe more than expected).

Fields of papers citing papers by Madelon Paauwe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madelon Paauwe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madelon Paauwe. The network helps show where Madelon Paauwe may publish in the future.

Co-authorship network of co-authors of Madelon Paauwe

This figure shows the co-authorship network connecting the top 25 collaborators of Madelon Paauwe. A scholar is included among the top collaborators of Madelon Paauwe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madelon Paauwe. Madelon Paauwe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphoma 2025 ·Leukemia & lymphoma ·Durga Bhavani Dandamudi,Iwona Konieczna,(unknown),(unknown),(unknown),(unknown),(unknown),Paul A. Ellis,Luis E. Rodrı́guez,Apurvasena Parikh,Tommy Li,Madelon Paauwe,Cormac Cosgrove,Adam S. Chervin,Edward B. Reilly,Pearlie K. Epling‐Burnette,Edith Szafer‐Glusman	0
2	Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model 2021 ·OncoTargets and Therapy ·Mark J.A. Schoonderwoerd,(unknown),(unknown),(unknown),Madelon Paauwe,Marije Slingerland,Marieke F. Fransen,Lukas J.A.C. Hawinkels	7
3	Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer 2021 ·eLife ·Andrea Sacchetti,Miriam Teeuwssen,(unknown),Rosalie Joosten,Tong Xu,(unknown),(unknown),Martin Watson,(unknown),Won Kyu Kim,Inge Ubink,Harmen J.G. van de Werken,Arianna Fumagalli,Madelon Paauwe,Jacco van Rheenen,Owen J. Sansom,Onno Kranenburg,Riccardo Fodde	43
4	Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy 2020 ·Clinical Cancer Research ·Mark J.A. Schoonderwoerd,(unknown),(unknown),(unknown),(unknown),Madelon Paauwe,Marieke C. Barnhoorn,Yingmiao Liu,Cornelis F.M. Sier,James C.H. Hardwick,Andrew B. Nixon,Charles P. Theuer,Marieke F. Fransen,Lukas J.A.C. Hawinkels	37
5	Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer 2020 ·Oncogene ·(unknown),Philip W. Voorneveld,(unknown),Eveline S. M. de Jonge‐Muller,Mark J.A. Schoonderwoerd,Madelon Paauwe,(unknown),(unknown),Gabi W. van Pelt,Wilma E. Mesker,Lukas J.A.C. Hawinkels,James C.H. Hardwick	20
6	Endoglin Targeting: Lessons Learned and Questions That Remain 2020 ·International Journal of Molecular Sciences ·Yingmiao Liu,Madelon Paauwe,Andrew B. Nixon,Lukas J.A.C. Hawinkels	23
7	Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress 2019 ·Cancer Research ·Irem Kaymak,(unknown),Werner Schmitz,Andrew D. Campbell,Beatrice Dankworth,Carsten P. Ade,Susanne Walz,Madelon Paauwe,Charis Kalogirou,(unknown),Mathias T. Rosenfeldt,David M. Gay,Grace H. McGregor,Owen J. Sansom,Almut Schulze	66
8	Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis 2018 ·Clinical Cancer Research ·Madelon Paauwe,Mark J.A. Schoonderwoerd,Roxan F.C.P. Helderman,Tom J. Harryvan,Arwin Groenewoud,Gabi W. van Pelt,(unknown),(unknown),Henri H. Versteeg,B. Ewa Snaar‐Jagalska,Charles P. Theuer,James C.H. Hardwick,Cornelis F.M. Sier,Peter ten Dijke,Lukas J.A.C. Hawinkels	132
9	Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer 2016 ·Oncogene ·Madelon Paauwe,(unknown),(unknown),Gabi W. van Pelt,Chao Cui,Charles P. Theuer,James C.H. Hardwick,Cornelis F.M. Sier,Lukas J.A.C. Hawinkels	56
10	Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors 2015 ·Clinical Cancer Research ·Lukas J.A.C. Hawinkels,Amaya García de Vinuesa,Madelon Paauwe,Marianna Kruithof‐de Julio,Eliza Wiercinska,Evangelia Pardali,Laura Mezzanotte,Stijn Keereweer,Tanya M. Braumuller,(unknown),Jos Jonkers,Clemens W.G.M. Löwik,Marie‐José Goumans,Timo L.M. ten Hagen,Peter ten Dijke	45
11	Fibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels 2015 ·Scientific Reports ·(unknown),Lukas J.A.C. Hawinkels,(unknown),Luuk te Riet,Madelon Paauwe,Marcel Vermeij,A.H. Jan Danser,Roland Kanaar,Peter ten Dijke,Jeroen Essers	21
12	Abstract 1370: Activin receptor-like kinase 1 ligand trap reduces microvascular density and improves chemotherapy efficiency to various solid tumors 2015 ·Cancer Research ·Lukas J.A.C. Hawinkels,Amaya García de Vinuesa,Madelon Paauwe,Marianna Kruithof‐de Julio,(unknown),Marie‐José Goumans,Timo Hagen,Peter ten Dijke	1
13	Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity 2014 ·Blood ·Rogier W. Rooswinkel,Bert van de Kooij,Evert de Vries,Madelon Paauwe,Rens Braster,Marcel Verheij,Jannie Borst	83
14	Endoglin for tumor imaging and targeted cancer therapy 2013 ·Expert Opinion on Therapeutic Targets ·Madelon Paauwe,Peter ten Dijke,Lukas J.A.C. Hawinkels	36
15	Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B 2013 ·Oncogene ·Bert van de Kooij,Rogier W. Rooswinkel,(unknown),(unknown),Evert de Vries,Madelon Paauwe,George M. C. Janssen,Peter A. van Veelen,Jannie Borst	18
16	Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts 2012 ·Oncogene ·Lukas J.A.C. Hawinkels,Madelon Paauwe,Hein W. Verspaget,Eliza Wiercinska,(unknown),Kattria van der Ploeg,Pim J. Koelink,J. Lindeman,Wilma E. Mesker,Peter ten Dijke,Cornelis F.M. Sier	217

About Madelon Paauwe

Madelon Paauwe is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 16 papers that have together received 805 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (8 papers), TGF-β signaling in diseases (7 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Cancer Research (261 citations), Oncology (380 citations) and Molecular Biology (456 citations). Madelon Paauwe has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Lukas J.A.C. Hawinkels, Peter ten Dijke, Cornelis F.M. Sier, Eliza Wiercinska, Wilma E. Mesker, Kattria van der Ploeg, Pim J. Koelink, Hein W. Verspaget, J. Lindeman and James C.H. Hardwick. Their work appears in journals such as Blood, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact